| Umbrella Lab Announces Documentation And Traceability Update For DSIP Peptide |
Globe Newswire |
05/07 |
05:09 |
| match.asia Introduces AI-Enabled Platform to Unlock Cross-Border M&A for SMEs |
Globe Newswire |
05/07 |
05:00 |
| GEN Korean BBQ Launches Costco Roadshow Series, Marking Next Phase of Retail Expansion |
Globe Newswire |
05/07 |
05:00 |
| Himax Technologies, Inc. Declares Cash Dividend for FY2025 |
Globe Newswire |
05/07 |
05:00 |
| Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial |
Globe Newswire |
05/07 |
04:57 |
| Temenos Launches Embedded AI Capabilities to Help Banks Move Faster, Stay in Control, and Create Better Experiences |
Globe Newswire |
05/07 |
03:27 |
| Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease |
Globe Newswire |
05/07 |
03:25 |
| Ashley Graham to Spotlight the Power of Authentic Partnerships as a Keynote Speaker at Licensing Expo 2026 |
Globe Newswire |
05/07 |
03:00 |
| Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease |
Globe Newswire |
05/07 |
02:14 |
| Shell announces commencement of a share buyback programme |
Globe Newswire |
05/07 |
02:03 |
| Shell plc First Quarter 2026 Interim Dividend |
Globe Newswire |
05/07 |
02:02 |
| Shell plc publishes first quarter 2026 press release |
Globe Newswire |
05/07 |
02:01 |
| Shell Plc 1st Quarter 2026 Unaudited Results |
Globe Newswire |
05/07 |
02:00 |
| Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders |
Globe Newswire |
05/07 |
01:05 |
| Zealand Pharma - Execution framework for share buy-back program |
Globe Newswire |
05/07 |
01:05 |
| SBM Offshore First Quarter 2026 Trading Update |
Globe Newswire |
05/07 |
01:02 |
| Zealand Pharma Announces Financial Results for the First Three Months of 2026 |
Globe Newswire |
05/07 |
01:00 |
| VALLOUREC RECORDS STRONG ENDORSEMENT OF ITS EMPLOYEE SHARE OFFERING |
Globe Newswire |
05/07 |
01:00 |
| Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026 |
Globe Newswire |
05/07 |
01:00 |
| Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth |
Globe Newswire |
05/07 |
01:00 |
| argenx Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/07 |
01:00 |
| Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program |
Globe Newswire |
05/07 |
00:55 |
| onsemi Announces Pricing of Private Offering of $1.3 Billion of 0% Convertible Senior Notes |
Globe Newswire |
05/07 |
00:41 |
| Suja Life Announces Pricing of Initial Public Offering |
Globe Newswire |
05/07 |
00:16 |
| SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support |
Globe Newswire |
05/06 |
23:18 |
